Changes in the incidence and etiological patterns of bacteremia associated with acute leukemia over a 25-year period

Internal Medicine

Volumn 37, Issue 12, 1998, Pages 1014-1018

  Funada, Hisashi ^b   Matsuda, Tamotsu ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Empiric antibiotic therapy; Gram negative bacilli; Gram positive cocci; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; CANDIDA; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; FREQUENCY ANALYSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HUMAN; INCIDENCE; INFECTION PREVENTION; JAPAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEUTROPENIA; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; STREPTOCOCCUS;

EID: 0032470056     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.1014     Document Type: Article

References (19)

1. Funada H, Machi T, MatsudaT. Bacteremia complicating acute leukemia with special reference to its incidence and changing etiological patterns. Jpn J Clin Oncol 18: 239-248, 1988.
2. Yokota T, Teshima H, Okajima Y, et al. Septicemia associated with hematopoietic disorders and its features according to respective primary disorders. Kansenshogaku Zasshi (J Jpn Assoc Infect Dis) 70: 108-115, 1996 (Abstract in English).
3. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 163: 951-958, 1991 (published erratum appears in J Infect Dis 164: 832, 1991).
4. Bone RC. Gram-positiveorganismsand sepsis. Arch Intern Med 154:26-34, 1994.
5. Funada H, Machi T, Matsuda T. Pseudomonas aeruginosa bacteremia associated with hematologic disorders [III]. Prognostic factors. Kansenshogaku Zasshi (J Jpn Assoc infect Dis) 63: 880-885, 1989 (Abstract in English).
6. Sakamoto M, Saruta K, Nakazawa Y, et al. Sepsis associated with hematological malignancies: prophylaxis of Pseudomonas aeruginosa sepsis. Kansenshogaku Zasshi (J Jpn Assoc Infect Dis) 70: 116-122, 1996.
7. Ohno R, Tomonaga M, Kobayashi T, et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 323: 871-877, 1990.
8. Funada H, Teshima H, Hattori K. Total intestinal decontamination for prevention of infection in bone marrow transplantation. Jpn J Clin Oncol 13 Suppl 1: 111-126, 1983.
9. Takami A, Shiobara S. Opportunistic infection in bone marrow transplantation: current prevention in Kanazawa University Bone Marrow Transplantation Team. Ketsueki Shuyoka (Hematol Oncol) 33: 235-241, 1996 (in Japanese).
10. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 6: 428-442, 1993.
11. Mastrianni DM, Tung NM, Tenen DG. Acute myelogenous leukemia: current treatment and future directions. Am J Med 92: 286-295, 1992.
12. Ohno R. Therapy for leukemias. Ninon Naika Gakkai Zasshi (J Jpn Soc Intern Med) 86: 477-480, 1997 (in Japanese).
13. Yu VL. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann Intern Med 94:784-785, 1981.
14. Kiehn TE, Armstrong D. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices. Eur J Clin Microbiol Infect Dis 9: 869-872, 1990.
15. Sakamoto M. Optimal antibacterial chemotherapy for infectious diseases associated with hematological malignancies. Kansenshogaku Zasshi (J Jpn Assoc Infect Dis) 71: 72-82, 1997 (Abstract in English).
16. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328: 1323-1332, 1993.
17. Ramphal R, Gucalp R, Rotstein C, Cimino M, Oblon D. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient. Am J Med 100 Suppl 6A: 83S-89S, 1996.
18. Funada H, Hattori K. Septicemia in acute leukemia. Jpn J Med 15: 115-124, 1976.
19. Ramphal R, Bolger M, Oblon DJ, et al. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study. Antimicrob Agents Chemother 36: 1062-1067, 1992.